KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Buildings (2016 - 2025)

Historic Buildings for Bristol Myers Squibb (BMY) over the last 12 years, with Q3 2025 value amounting to $7.1 billion.

  • Bristol Myers Squibb's Buildings rose 1010.82% to $7.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 billion, marking a year-over-year increase of 1010.82%. This contributed to the annual value of $6.6 billion for FY2024, which is 132.41% up from last year.
  • As of Q3 2025, Bristol Myers Squibb's Buildings stood at $7.1 billion, which was up 1010.82% from $6.9 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Buildings registered a high of $7.1 billion during Q3 2025, and its lowest value of $5.6 billion during Q1 2021.
  • Moreover, its 5-year median value for Buildings was $6.0 billion (2023), whereas its average is $6.2 billion.
  • Its Buildings has fluctuated over the past 5 years, first tumbled by 403.56% in 2021, then soared by 1044.87% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Buildings (Quarter) stood at $5.9 billion in 2021, then grew by 0.39% to $5.9 billion in 2022, then grew by 9.71% to $6.5 billion in 2023, then grew by 1.32% to $6.6 billion in 2024, then increased by 8.25% to $7.1 billion in 2025.
  • Its last three reported values are $7.1 billion in Q3 2025, $6.9 billion for Q2 2025, and $6.6 billion during Q1 2025.